Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

NMR Resonance Assignment Methodology: Characterizing Large Sparsely Labeled Glycoproteins.

Chalmers GR, Eletsky A, Morris LC, Yang JY, Tian F, Woods RJ, Moremen KW, Prestegard JH.

J Mol Biol. 2019 May 31;431(12):2369-2382. doi: 10.1016/j.jmb.2019.04.029. Epub 2019 Apr 26.

PMID:
31034888
2.

Paramagnetic Tag for Glycosylation Sites in Glycoproteins: Structural Constraints on Heparan Sulfate Binding to Robo1.

Moure MJ, Eletsky A, Gao Q, Morris LC, Yang JY, Chapla D, Zhao Y, Zong C, Amster IJ, Moremen KW, Boons GJ, Prestegard JH.

ACS Chem Biol. 2018 Sep 21;13(9):2560-2567. doi: 10.1021/acschembio.8b00511. Epub 2018 Aug 16.

PMID:
30063822
3.

Structural Aspects of Heparan Sulfate Binding to Robo1-Ig1-2.

Gao Q, Chen CY, Zong C, Wang S, Ramiah A, Prabhakar P, Morris LC, Boons GJ, Moremen KW, Prestegard JH.

ACS Chem Biol. 2016 Nov 18;11(11):3106-3113. Epub 2016 Sep 29.

4.

SPECT/CT Assessment of Infected Intracardiac Devices With and Without Attenuation Correction.

Morris LC, Bradshaw ML.

J Nucl Med Technol. 2016 Jun;44(2):94-5. doi: 10.2967/jnmt.115.156844. Epub 2015 Aug 13. Review.

5.

Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).

Morris LC, Nance KD, Gentry PR, Days EL, Weaver CD, Niswender CM, Thompson AD, Jones CK, Locuson CW, Morrison RD, Daniels JS, Niswender KD, Lindsley CW.

J Med Chem. 2014 Dec 11;57(23):10192-7. doi: 10.1021/jm501375c. Epub 2014 Dec 2.

6.

Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Chen Z, Guo L, Zhang Y, Walzem RL, Pendergast JS, Printz RL, Morris LC, Matafonova E, Stien X, Kang L, Coulon D, McGuinness OP, Niswender KD, Davies SS.

J Clin Invest. 2014 Aug;124(8):3391-406. doi: 10.1172/JCI72517. Epub 2014 Jun 24.

7.

Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis.

Kocalis HE, Hagan SL, George L, Turney MK, Siuta MA, Laryea GN, Morris LC, Muglia LJ, Printz RL, Stanwood GD, Niswender KD.

Mol Metab. 2014 Feb 19;3(4):394-407. doi: 10.1016/j.molmet.2014.01.014. eCollection 2014 Jul.

8.

Sparse labeling of proteins: structural characterization from long range constraints.

Prestegard JH, Agard DA, Moremen KW, Lavery LA, Morris LC, Pederson K.

J Magn Reson. 2014 Apr;241:32-40. doi: 10.1016/j.jmr.2013.12.012. Review.

9.

A Duplexed High-Throughput Screen to Identify Allosteric Modulators of the Glucagon-Like Peptide 1 and Glucagon Receptors.

Morris LC, Days EL, Turney M, Mi D, Lindsley CW, Weaver CD, Niswender KD.

J Biomol Screen. 2014 Jul;19(6):847-58. doi: 10.1177/1087057114520971. Epub 2014 Feb 13.

10.

Chemical shift prediction for denatured proteins.

Prestegard JH, Sahu SC, Nkari WK, Morris LC, Live D, Gruta C.

J Biomol NMR. 2013 Feb;55(2):201-9. doi: 10.1007/s10858-012-9702-x. Epub 2013 Jan 8.

11.

Assignment of protein backbone resonances using connectivity, torsion angles and 13Calpha chemical shifts.

Morris LC, Valafar H, Prestegard JH.

J Biomol NMR. 2004 May;29(1):1-9.

PMID:
15017135
13.

Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.

Chang YC, Cherniak R, Kozel TR, Granger DL, Morris LC, Weinhold LC, Kwon-Chung KJ.

Infect Immun. 1997 May;65(5):1584-92.

14.

Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 5 as determined by NMR spectroscopy.

Kalelkar S, Glushka J, van Halbeek H, Morris LC, Cherniak R.

Carbohydr Res. 1997 Apr 21;299(3):119-28.

PMID:
9163894
15.

Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.

Cherniak R, Morris LC, Belay T, Spitzer ED, Casadevall A.

Infect Immun. 1995 May;63(5):1899-905.

16.

Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDS.

Cherniak R, Morris LC, Meyer SA, Mitchell TB.

Carbohydr Res. 1993 Nov 3;249(2):405-13. No abstract available.

PMID:
8275508
17.
19.

Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.

Cherniak R, Morris LC, Anderson BC, Meyer SA.

Infect Immun. 1991 Jan;59(1):59-64.

20.

Blue Cross and Blue Shield: looking at links with PROs.

Morris LC.

Internist. 1984 Jan;25(1):14-5. No abstract available.

PMID:
10273463
21.

A case of unilateral atrophic kidney unaccompanied by hypertension.

MORRIS LC, STARR W, CLAYBAUGH G.

Q Bull Northwest Univ Med Sch. 1957;31(3):253-60. No abstract available.

22.

Streptomycin in the treatment of pulmonary tuberculosis; report of 15 patients.

SHAMASKIN A, MORRIS LC, et al.

Am Rev Tuberc. 1947 Dec;56(6):540-51. No abstract available.

PMID:
18918477

Supplemental Content

Loading ...
Support Center